EQS-CMS: Evotec SE: Release of a capital market information

17.11.25 15:27 Uhr

Werte in diesem Artikel
Aktien

5,21 EUR 0,13 EUR 2,48%

EQS Post-admission Duties announcement: EVOTEC SE / Completion of Share Repurchase Programme / Announcement pursuant to Article 5(1)(b), (3) of Regulation (EU) No. 596/2014 in conjunction with Article 2(2) and (3) of Delegated Regulation (EU) 2016/1052
Evotec SE: Release of a capital market information

17.11.2025 / 15:27 CET/CEST
Dissemination of a Post-admission Duties announcement transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

Wer­bung


Completion of Share Repurchase Programme / Announcement pursuant to Article 5(1)(b), (3) of Regulation (EU) No. 596/2014 in conjunction with Article 2(2) and (3) of Delegated Regulation (EU) 2016/1052

The share repurchase programme of Evotec SE, the commencement of which was announced on 6 November 2025 in accordance with Article 5(1)(a) of Regulation (EU) No. 596/2014 and Article 2(1) of Delegated Regulation (EU) 2016/1052 for 7 November 2025, was completed within the published acquisition period from 7 November 2025 (earliest possible acquisition date) to 17 December 2025 (latest possible acquisition date).

From 7 November 2025 (inclusive) through 14 November 2025 (inclusive), a total of 290,000 shares were acquired under the share repurchase programme at a volume-weighted average price of EUR 5.3711 (total volume: EUR 1,545,734.24):

Wer­bung

Date Shares Volume-weighted average price (EUR) Transaction amount (EUR)
07.11.2025 75,000 5.4559 409,193.25
10.11.2025 75,000    5.2409 393,067.58   
11.11.2025 45,758    5.1554 235,900.70   
12.11.2025 50,000    5.3860 269,300.95   
13.11.2025 24,242    5.5243 133,919.64   
14.11.2025 20,000    5.2176 104,352.12   
Total 290,000 5.3711 1,545,734.24


The shares were acquired by a credit institution commissioned by Evotec SE exclusively via the Frankfurt Stock Exchange (Xetra). The detailed transactions have been published on the Evotec SE website (https://www.evotec.com/share-buy-back-program).



17.11.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News

Wer­bung


Language: English
Company: Evotec SE
Manfred Eigen Campus / Essener Bogen 7
22419 Hamburg
Germany
Internet: www.evotec.com

 
End of News EQS News Service

2231134  17.11.2025 CET/CEST

Ausgewählte Hebelprodukte auf EVOTEC

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf EVOTEC

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu EVOTEC SE

Wer­bung

Analysen zu EVOTEC SE

DatumRatingAnalyst
12.11.2025EVOTEC SE OutperformRBC Capital Markets
07.11.2025EVOTEC SE HoldDeutsche Bank AG
06.11.2025EVOTEC SE HoldDeutsche Bank AG
05.11.2025EVOTEC SE OutperformRBC Capital Markets
09.10.2025EVOTEC SE HoldDeutsche Bank AG
DatumRatingAnalyst
12.11.2025EVOTEC SE OutperformRBC Capital Markets
05.11.2025EVOTEC SE OutperformRBC Capital Markets
03.09.2025EVOTEC SE OutperformRBC Capital Markets
13.08.2025EVOTEC SE BuyWarburg Research
13.08.2025EVOTEC SE OutperformRBC Capital Markets
DatumRatingAnalyst
07.11.2025EVOTEC SE HoldDeutsche Bank AG
06.11.2025EVOTEC SE HoldDeutsche Bank AG
09.10.2025EVOTEC SE HoldDeutsche Bank AG
31.07.2025EVOTEC SE HoldDeutsche Bank AG
22.07.2025EVOTEC SE HoldDeutsche Bank AG
DatumRatingAnalyst
03.03.2025EVOTEC SE SellDeutsche Bank AG
25.11.2024EVOTEC SE SellDeutsche Bank AG
18.11.2024EVOTEC SE SellDeutsche Bank AG
12.11.2024EVOTEC SE SellDeutsche Bank AG
07.11.2024EVOTEC SE SellDeutsche Bank AG

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für EVOTEC SE nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen